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Bidirectional nucleolar dysfunction in
C9orf72 frontotemporal lobar degeneration
Sarah Mizielinska1,2†, Charlotte E. Ridler1†, Rubika Balendra1,3†, Annora Thoeng1, Nathan S. Woodling3,
Friedrich A. Grässer4, Vincent Plagnol5, Tammaryn Lashley6, Linda Partridge3,7 and Adrian M. Isaacs1*
Abstract
An intronic GGGGCC expansion in C9orf72 is the most common known cause of both frontotemporal lobar
degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). The repeat expansion leads to the generation of sense and
antisense repeat RNA aggregates and dipeptide repeat (DPR) proteins, generated by repeat-associated
non-ATG translation. The arginine-rich DPR proteins poly(glycine-arginine or GR) and poly(proline-arginine
or PR) are potently neurotoxic and can localise to the nucleolus when expressed in cells, resulting in enlarged nucleoli with
disrupted functionality. Furthermore, GGGGCC repeat RNA can bind nucleolar proteins in vitro. However, the relevance of
nucleolar stress is unclear, as the arginine-rich DPR proteins do not localise to the nucleolus in C9orf72-associated FTLD/ALS
(C9FTLD/ALS) patient brain. We measured nucleolar size in C9FTLD frontal cortex neurons using a three-dimensional,
volumetric approach. Intriguingly, we found that C9FTLD brain exhibited bidirectional nucleolar stress. C9FTLD neuronal
nucleoli were significantly smaller than control neuronal nucleoli. However, within C9FTLD brains, neurons containing
poly(GR) inclusions had significantly larger nucleolar volumes than neurons without poly(GR) inclusions. In
addition, expression of poly(GR) in adult Drosophila neurons led to significantly enlarged nucleoli. A small but significant
increase in nucleolar volume was also observed in C9FTLD frontal cortex neurons containing GGGGCC repeat-containing
RNA foci. These data show that nucleolar abnormalities are a consistent feature of C9FTLD brain, but that diverse
pathomechanisms are at play, involving both DPR protein and repeat RNA toxicity.
Keywords: C9orf72, FTLD, Nucleolar stress, Dipeptide repeat proteins, Poly(GR), RNA foci
Introduction
An intronic GGGGCC expansion in C9orf72 is the most
common known cause of both frontotemporal lobar
dementia (FTLD) and amyotrophic lateral sclerosis
(ALS) [7, 27]. Healthy individuals have fewer than 30
repeats, whereas patients have several hundred to several
thousand repeats [2, 7, 33]. The repeat expansion muta-
tion might cause pathogenesis by loss of function of the
C9orf72 protein, or gain-of-function mechanisms from i)
sense and antisense repeat RNA and/or ii) the dipeptide
repeat proteins poly(GA), poly(GP), poly(GR), poly(PR)
and poly(AP), which are generated by repeat-associated
non-ATG translation [28].
Previously, over-expression of poly(GR) and poly(PR)
were reported to be extremely toxic to adult Drosophila
neurons and primary rat neurons [19, 34]. Over-
expression of poly(GR) or poly(PR) repeats in cell
models leads to their localisation in the nucleolus, and
results in enlarged nucleoli and altered ribosomal RNA
processing [13, 32, 34]. Additionally, nucleolar proteins
modify poly(PR) toxicity in yeast [12]. C9orf72 repeat
RNA has been shown to bind nucleolar proteins in vitro,
suggesting that RNA toxicity may also contribute to
nucleolar dysfunction [5, 10]. Dispersal of the nucleolar
protein nucleolin was observed within neurons of adult
C9orf72 BAC transgenic mice, but no consequent
change in ribosomal RNA biogenesis was detected [23].
However, enlarged nucleoli and altered ribosomal RNA
processing have been reported in cells derived from
patients with a C9orf72 repeat expansion, including
lymphocytes, fibroblasts and induced pluripotent stem
cells differentiated into neurons [10]. Increases in
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nucleolar size and number are generally considered to be
a consequence of cell demand for ribosome biogenesis,
and are a hallmark of tumour cells in cancer [30].
However, disruption of nucleolar structure and ribosomal
RNA transcription have also been reported in several
neurodegenerative diseases, both in post-mortem patient
tissue and animal models [25].
Recent proteomic studies have found that the binding
partners of the arginine-rich DPR proteins are enriched in
proteins containing low-complexity domains (LCDs),
which are often found in membraneless organelles such as
the nucleolus [14, 15]. The LCDs facilitate liquid-liquid
phase separation, enabling cellular partitioning of mem-
braneless organelles. The nucleolar protein nucleophos-
min has an LCD that is bound by poly(GR) and poly(PR),
altering its phase-separation properties and leading to al-
tered nucleolar dynamics in cell culture assays [14]. These
data suggest that disruption of the function of membrane-
less organelles is an important pathway in C9FTLD/ALS
pathogenesis, and consequently confirmation of these
findings in patient tissue is a key next step.
The relevance of nucleolar stress to disease pathogenesis
has been questioned, as poly(GR) and poly(PR) inclusions
do not localise to the nucleolus in C9FTLD/ALS patient
brain and nucleolar size was reported to be unaffected in
a small sample of C9FTLD/ALS brains [31]. To provide
clarity to this important issue, we measured nucleolar size
in C9FTLD brains using a three-dimensional, volumetric
approach, rather than single-plane area measurements.
We show here, for the first time, that nucleolar stress
does occur in C9FTLD patient brain in a bidirectional
manner and is associated with both repeat RNA and
poly(GR) pathology.
Materials and methods
Human cases
Brain specimens (described in Additional file 1: Table
S1) were obtained from Queen Square Brain Bank for
Neurological Disorders, UCL Institute of Neurology,
London. Samples were fixed in 10% buffered formalin
for histopathology and immunohistochemistry. Histo-
logical sections from the anterior frontal F1-F2 region
were analysed. We analysed eight controls with no
known neurodegenerative disease, eight cases with het-
erozygous C9orf72 repeat expansions, and one homozy-
gous repeat expansion case. Seven expansion cases
(cases 9, 12, 14–18) were previously described [20], in-
cluding the homozygous repeat expansion case (case 17)
[8]. The neuropathological diagnosis was determined
using established diagnostic criteria, in line with consen-
sus recommendations for the FTLD spectrum [16]. This
study was approved by the UCL Institute of Neurology
and National Hospital for Neurology and Neurosurgery
Local Research Ethics Committee.
Fly stocks and husbandry
All fly stocks were maintained and experiments
conducted at 25 °C on a 12 h:12 h light:dark cycle at 60%
constant humidity, on standard sugar-yeast food contain-
ing 15 g/L agar, 50 g/L sugar, 100 g/L brewer’s yeast,
30 ml/L nipagin (10% in ethanol) and 3 ml/L propionic
acid). RU486 (Sigma) dissolved in ethanol was added to a
final concentration of 200 μM. Published transgenic fly
lines expressing 100 repeats of the DPR proteins GR and
glycine-alanine (GA), under the upstream activating
sequence (UAS) promoter, were used [19]. Expression of
these DPR proteins was restricted to adult neurons using
the inducible elav-GeneSwitch driver [24]. Two days after
eclosion adult elav-GeneSwitch > (GR)100 and elav-
GeneSwitch > (GA)100 flies were fed with food containing
200 μM RU486 to induce expression of the DPR proteins,
or with no RU486 as a control, for 7 days.
Immunofluorescence
Human post-mortem brain
Twenty micrometer-thick paraffin-embedded sections of
human post-mortem frontal cortex tissue were dewaxed
in xylene and rehydrated in graded alcohols, followed by
antigen-retrieval in proteinase K (S3020, Dako) for 2
mins, and pressure cooking in citrate buffer (0.1 M,
pH6) for 10 mins. Following a PBS wash, sections were
blocked in 10% foetal bovine serum in PBS for 30 mins,
and then incubated with primary antibody in PBS over-
night at 4 °C. The following primary antibodies were
used: nucleophosmin (1:1000, Abcam, ab10530), nucleo-
lin (1:50, Santa Cruz, sc-8031), NeuN (1:1000, Millipore,
ABN78), and 5H9 antibody against poly(GR) (1:25, [21]).
Samples were then washed in PBS and incubated with
the appropriate secondary antibodies (Alexa Fluor, Life
Technologies, 1:500 in PBS) for 1 h at room temperature.
To reduce autofluorescent background, a 10 min incuba-
tion was carried out in Sudan black B (Sigma, 0.2% in 70%
ethanol/30% PBS) followed by additional PBS washes.
Samples were mounted using ProLong® Gold Antifade
Mountant with DAPI (Life Technologies).
Drosophila
Brains were dissected in PBS containing 0.3% Triton-X
(PBST) and then fixed in 4% PFA in PBST at room
temperature for 15 min. Brains were washed three
times in PBST, blocked in 10% bovine serum albumin
(BSA) in PBST for 1 h at room temperature, and then
incubated in primary antibody in 10% BSA in PBST at
4 °C for 48 h. The following primary antibodies were
used: poly(GR) (1:25, 5H9 - as above), poly(GA)
(1:300, Cosmobio, CAC-TIP-C9-P01), fibrillarin
(1:400, Abcam, ab4566). Brains were washed in PBST
and incubated with appropriate secondary antibodies
(Alexa Fluor, Life Technologies, 1:250 in 10% BSA in
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PBST) at 4 °C overnight. Brains were then washed
three times in PBST and whole mounted onto glass
slides in VECTASHIELD® mounting medium with
DAPI (Vector Laboratories, H-1200).
RNA fluorescent in situ hybridisation with
immunofluorescence
Twenty micrometer-thick paraffin-embedded sections of
human post-mortem frontal cortex tissue were dewaxed
followed by antigen-retrieval as above. The protocol was
then continued as per Mizielinska et al., 2013 [20].
Briefly, sections were washed in 2 × SSC and incubated
for 30 min in pre-hybridisation solution (50% formam-
ide/2 × SSC) at 80 °C, and hybridised with a (GGCCCC)4
2′-O-methyl RNA probe labelled with Cy3 (Integrated
DNA Technologies) for 2 h at 80 °C in hybridisation
solution (50% formamide, 2 × SSC, 0.8 mg/ml tRNA,
0.8 mg/ml salmon sperm DNA, 0.16% BSA, 8% dex-
tran sulphate, 1.6 mM ribonucleoside vanadyl complex,
5 mM EDTA, 0.2 ng/μl probe). Sections were washed
three times for 30 min each in 50% formamide/0.5 × SSC
at 80 °C, and then three times for 10 min at room
temperature in 0.5 × SSC. After a brief wash in PBS,
immunostaining was continued from blocking as above.
Image acquisition and quantification of nucleolar volume
Images of human post-mortem brain were acquired
using an LSM710 confocal microscope (Zeiss) using a
plan-apochromat 40×/1.4 NA oil immersion objective.
Fluorescence intensity was set to peak for each patient
to account for case-to-case variability. Images of
Drosophila brains were acquired with an LSM700
confocal microscope (Zeiss) using a plan-apochromat
63× oil/1.4 NA immersion objective and the same set-
tings for all images.
Immunofluorescence of human post-mortem brain
Twenty z-stack images were acquired per sample,
consisting of twelve 2 μm z-planes of 2084 × 2084 pixels,
over a 20 μm depth (of which approximately 14 μm
contained tissue after processing). A minimum of 200
neurons were analysed (range 217–973), including a
minimum of 16 poly(GR) aggregate-bearing neurons
(range 16–139) per C9FTLD frontal cortex. For detec-
tion of nuclei, nucleoli and NeuN, gain was adjusted to
peak intensity for each patient. Three-dimensional
volumetric analysis of confocal images was performed using
Volocity image analysis software (Perkin Elmer). Nucleoli
(identified by either nucleophosmin or nucleolin), DAPI-
stained nuclei and NeuN-positive neurons were iden-
tified by fluorescence-intensity threshold a set number
of standard deviations above mean voxel intensity for
each image. As poly(GR) aggregates are present in
C9FTLD patient sections but not control sections, an
absolute intensity threshold was used for detection.
Low-level poly(GR) signal was observed inside the
nucleolus in both cases and controls and was conse-
quently excluded as background. No intra-nucleolar
poly(GR) aggregates were observed by eye. Objects
defined as nucleoli, poly(GR) aggregates and nuclei
were compartmentalised into NeuN-positive neurons
to give the volume of each stain present in each
neuron. Occasionally neurons contained more than
one nucleoli; the volumes of these structures were
combined for analysis. Neurons in which no nucleolar
stain was detected were excluded from analysis.
Immunofluorescence of Drosophila
Four z-stack images covering a 15 μm depth were taken
from each Drosophila brain, achieving a minimum of 174
nucleoli per brain (range 174–920), including a minimum
of five poly(GR) (range 5–63) or eight poly(GA) aggregates
(range 8–53). Image acquisition and volumetric analysis of
DAPI-stained nuclei, nucleoli and poly(GR) or poly(GA)
aggregates was performed similarly to human post-
mortem brain, except that no exclusion of background
nucleolar staining of aggregates was required and aggre-
gates were assigned to nucleoli by proximity of the
centroids. Occasional low-level staining of poly(GR) or
poly(GA) was observed in uninduced flies owing to the
known leaky expression of the elav-GeneSwitch driver
[26]; nucleoli associated with these aggregates were
excluded from the subsequent analysis.
RNA fluorescent in situ hybridisation with
immunofluorescence in human post-mortem brain
Ten to seventeen z-stack images at 2084 × 2084 pixels
covering a 20 μm depth were acquired to ensure a
minimum of 100 neurons were analysed (range 134–
232), including a minimum of 38 RNA foci-bearing
neurons (range 38–88) per C9FTLD frontal cortex.
Image acquisition and volumetric analysis of nucleoli
and poly(GR) aggregates was performed similarly to
human post-mortem brain immunofluorescence ana-
lysis described above; RNA foci were additionally
counted using the touch count tool; neurons were
determined either by NeuN-positive staining or by
morphology (size and DAPI staining).
Statistical analysis
Data are presented as median nucleolar or nuclear volume
per individual patient or fly owing to the non-normal
distribution of volumes in all data sets. Unpaired t
tests were carried out to compare median nucleolar
and nuclear volumes between control and C9FTLD
patient brain, and between uninduced and induced
(GR)100 or (GA)100 transgenic Drosophila. Paired regres-
sion analysis was carried out between neurons with and
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without pathology (DPR protein inclusions or RNA foci)
in C9FTLD patient brain or Drosophila.
Results
Nucleolar volume is reduced in C9FTLD patient brain
To determine whether nucleolar volume was altered in
C9FTLD patient brain, we used confocal microscopy to
capture three-dimensional z-stack images from sections
of frontal cortex in eight heterozygous and one homozy-
gous C9FTLD case, and eight non-neurodegenerative
disease controls (details of cases in Additional file 1:
Table S1). These sections were stained for two nucleolar
markers (nucleophosmin and nucleolin) the neuronal
marker NeuN. Both control and patient brain displayed
clear nucleophosmin-positive nucleoli in neurons
(Fig. 1a). Analysis of at least 200 neurons per case
showed no difference in the number of nucleophosmin-
positive nucleoli between controls and C9FTLD cases,
with most cells containing only one nucleolar structure
(Additional file 1: Figure S1a). Plotting a frequency
distribution of total nucleophosmin volume per neuron
showed a broad distribution in both control and
C9FTLD patient frontal cortex, but with C9FTLD
patient neurons showing a shift towards reduced
volumes of nucleophosmin per cell (Fig. 1b). Analysis
of median nucleophosmin volume showed that
C9FTLD cases had on average 26% smaller nucleoli in
frontal cortical neurons than control cases (9.0 ± 1.0
versus 12.2 ± 0.9 μm3, p < 0.05, Fig. 1c). Median nucleo-
phosmin volume in the single homozygous C9FTLD case
was at the bottom of the range observed for heterozygous
cases. Importantly, there was no difference in median
nuclear volume between controls and C9FTLD cases
(Additional file 1: Figure S1b), indicating that the observed
change in nucleolar volume was not simply due to
enlarged nuclei. Nucleophosmin volume in neurons
showed a weak correlation with nuclear volume
(Additional file 1: Figure S1c and d), therefore nucleolar
volumes were not corrected for nuclear volume. Analysis
of the distinct nucleolar marker nucleolin showed that
median nucleolin volume was lower than nucleophosmin
volume, with no difference in the number or volume of
nucleolin-positive structures identified (Additional file 1:
Figure S2). These data show that the nucleophosmin-
positive nucleolar volume is decreased in neurons from
C9FTLD frontal cortex compared with controls.
Nucleolar volume is increased in poly(GR) inclusion-bearing
neurons in C9FTLD patient brain
We next investigated whether nucleolar volume was
altered in the presence of C9FTLD-specific pathologies.
The data for C9FTLD nucleolar volume were segregated
into poly(GR) inclusion-bearing and non-inclusion bear-
ing neurons, as the sections were also immunostained
for poly(GR) protein (Fig. 2a). We analysed images that
contained both GR-positive and -negative neurons to
ensure the laminar distribution of each population was
matched. Only cytoplasmic poly(GR) inclusions were
assessed as nuclear inclusions were too infrequent for
analysis. In these data, C9FTLD frontal cortical neurons
bearing a poly(GR) inclusion showed no change in the
number of nucleophosmin-positive nucleoli per cell
compared to neurons without an inclusion (Additional
file 1: Figure S3a), but a strong shift towards increased
nucleophosmin volumes (Fig. 2b). Analysis of median
nucleophosmin volume per case showed that C9FTLD
poly(GR) inclusion-bearing neurons had 87% bigger
nucleoli on average than neurons without an inclusion
(15.7 ± 1.9 versus 8.7 ± 1.0 μm3, p < 0.0001, Fig. 2c).
Median nucleophosmin volume in the single homozy-
gous C9FTLD case was not notably different from
heterozygous cases. No differences were detected in
nuclear volume between neurons with or without inclu-
sions (Additional file 1: Figure S3b). There was no
change in the number of nucleolin structures per nuclei,
but median nucleolin volume was increased on average
by 74% in poly(GR) inclusion-bearing neurons in
C9FTLD cases compared to neurons without inclusions
(9.1 ± 0.9 versus 5.2 ± 0.5 μm3, p < 0.001, Additional file
1: Figure S4). Notably, cytoplasmic poly(GR) inclusions
were present in 6.2 ± 1.3 and 6.4 ± 1.3% of neurons in
nucleophosmin and nucleolin datasets, respectively.
These data show that nucleolar volume is considerably
enlarged in C9FTLD neurons that contain poly(GR)
inclusions compared with those without.
Nucleolar enlargement can be evoked by expression of
poly(GR) protein in vivo
As pathologies from the five distinct DPR proteins at
least partially overlap in patient tissue [21], we investi-
gated the potential for individual DPR proteins to exert
changes in nucleolar morphology in isolation, but still
within an in vivo system. We analysed Drosophila lines
expressing either 100 repeats of poly(GR) or of poly(GA)
in adult neurons, both of which we have previously
shown to display neurotoxicity [19]. Inclusions of both
poly(GA) and poly(GR) were found to be widely distrib-
uted throughout Drosophila brains (Fig 3a), being
present in 7.8 ± 2.3 and 6.6 ± 1.9% of neurons, respect-
ively (Additional file 1: Figure S5). Neuronal nucleoli
associated with poly(GR) inclusions were about 18-fold
larger on average than nucleoli without inclusions (10.6 ±
3.3 versus 0.60 ± 0.03 μm3, p < 0.001), which were no
different to nucleoli in control flies (Fig. 3b). Neuronal
nucleoli associated with poly(GA) inclusions in GA(100)
flies were 1.5-fold larger than nucleoli without inclu-
sions (0.83 ± 0.04 versus 0.53 ± 0.03 μm3, p < 0.001), which
were again the same size as nucleoli in control flies
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(Fig. 3c). These findings show that the arginine-rich DPR
protein poly(GR) can exert nucleolar stress to a far greater
extent than poly(GA) in vivo.
Nucleolar volume is increased in RNA foci-bearing neurons
in C9FTLD patient brain
In addition to reports of association between the
arginine-rich DPR proteins and the nucleolus, C9orf72
sense repeat RNA has also been shown to bind nucleolar
proteins in vitro [5, 10]. To investigate whether any
changes in nucleolar volume were associated with RNA
foci in patient tissue, we performed fluorescent in situ
hybridisation for C9orf72 sense RNA combined with
immunofluorescence for the nucleolar marker nucleo-
phosmin on C9FTLD patient frontal cortex (Fig. 4a).
Tissue was also stained for poly(GR) protein, and
neurons containing poly(GR) inclusions were excluded
from the analysis (Additional file 1: Figure S6a–c). RNA
foci were present in an average of 35.0 ± 4.3% of neurons
(Additional file 1: Figure S6b). C9FTLD frontal cortical
neurons bearing sense RNA foci showed no difference in
the number of nucleophosmin-positive nucleoli per cell
(Additional file 1: Figure S6d), but a small shift towards
increased nucleophosmin volume compared with
neurons without foci (Fig. 4b). Analysis of median
nucleophosmin volume per case showed that RNA foci--
bearing neurons had on average 24% bigger nucleoli
than neurons without foci (10.0 ± 1.1 versus 8.1 ±
0.9 μm3, p < 0.05, Fig. 4c). We were not able to deter-
mine nuclear size as DAPI staining was not robust
enough to enable volume analysis after our combined
FISH and immunostaining protocol (FISH at 80 °C
Fig. 1 Decreased nucleolar volume in neurons from C9FTLD patient brain compared with neurons from neurologically-normal control brain. a
Representative images of frontal cortex from neurologically-normal controls and heterozygous (C9 Het) and homozygous (C9 Hom) C9FTLD cases
immunostained for the nucleolar protein nucleophosmin (NPM, green), the neuronal marker (NeuN, magenta) with DAPI nuclear stain (blue). Scale
bar represents 2 μm. b, c Quantification of neuronal nucleolar volume determined by nucleophosmin immunoreactivity. Frequency distribution of
pooled control and C9FTLD (heterozygous cases only) nucleolar volumes show a shift to reduced volumes in C9FTLD cases (b). Median nucleolar
volume was significantly decreased in C9FTLD cases compared with controls (c). Each dot represents an individual case with the homozygous
C9FTLD case shown in red, and the average and SEM of heterozygous cases shown as long and short horizontal bars, respectively. Significance
was determined by unpaired t test: *p < 0.05
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and protease antigen retrieval). However, reanalysing
a previous data set using four of the six cases
described here [20] showed no difference in nuclear
volume between neurons with or without RNA foci
(Additional file 1: Figure S6e). Interestingly, an
average of 18.4 ± 1.4% of RNA foci were observed to
colocalise with nucleophosmin, mostly on the edge of
the nucleolar structure (Additional file 1: Figure S7a, b).
In fact, in RNA foci-bearing neurons, nucleoli directly
associated with foci had a 26% larger nucleophosmin
volume than neurons where foci were present only in
the nucleoplasm (11.8 ± 1.5 versus 9.3 ± 1.0 μm3, p <
0.01, Additional file 1: Figure S7c). This finding
suggests that RNA foci induce nucleolar enlargement
predominantly through direct interaction with the
nucleophosmin component of nucleoli.
Discussion
Here, we present evidence for C9orf72 mutation-
associated nucleolar alterations in patient brain. Using
three-dimensional volumetric imaging, we have unveiled
bidirectional changes in nucleolar size in C9FTLD patient
brain. When comparing all frontal cortical neurons
irrespective of the presence of RNA or protein pathology,
C9FTLD cells had a smaller nucleophosmin-positive
nucleolar volume than those in non-neurodegenerative
control brains. However, within C9FTLD neurons, the
presence of poly(GR) inclusions or RNA foci resulted in
significant enlargement of nucleoli.
Thus far striking in vitro evidence exists for increased
nucleolar size in both cells overexpressing the arginine-
rich DPR proteins [13, 32, 34], and cells derived from
C9FTLD/ALS patients [10]. However, it is perhaps
unsurprising that neurons in C9FTLD frontal cortex
displayed an overall reduction in nucleolar size, as this
type of nucleolar stress has been observed in several
other neurodegenerative diseases [25]. Nucleolar shrink-
age would be expected to reduce ribosome biogenesis
and generally decrease cell metabolism. Indeed, reduced
ribosomal RNA maturation has been reported in C9ALS
patient lymphocytes and motor cortex [10]. Acutely, this
change might be protective under conditions of cell
stress by limiting energy expenditure, but chronically
would result in cell damage and ultimately cell death [9].
The nucleolar protein nucleophosmin is known to be
downregulated upon excitotoxic stimuli in neurons and
Fig. 2 Increased nucleolar volume in poly(GR) inclusion-bearing neurons in C9FTLD patient brain. a Representative images of frontal cortex from
a heterozygous C9FTLD case immunostained for the nucleolar protein nucleophosmin (NPM, green), poly(GR) protein (red), the neuronal marker
(NeuN, magenta) with DAPI nuclear stain (blue); a typical poly(GR) inclusion is arrowed. Scale bar represents 2 μm. b, c Quantification of neuronal
nucleolar volume determined by nucleophosmin immunoreactivity. Frequency distribution of pooled C9FTLD (heterozygous cases only) nucleolar
volumes show a shift to increased volumes in neurons bearing poly(GR) inclusions compared with neurons without inclusions (b). Median nucleolar
volume in C9FTLD cases was significantly larger in neurons with poly(GR) inclusions (GR+) compared with neurons without inclusions (GR-) (c). Each
dot represents an individual case with the homozygous C9FTLD case shown in red, grey lines link medians from the same cases in neurons with or
without poly(GR) inclusions, and the average and SEM of heterozygous cases are shown as long and short horizontal bars, respectively. Significance was
determined by paired regression analysis: ****p < 0.0001
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can increase levels of the classic nucleolar stress marker
p53; however, nucleophosmin-induced cell death appears
to be p53-independent [17].
In agreement with previous in vitro evidence (detailed
above), we also unveiled a second type of nucleolar
stress in C9FTLD neurons containing inclusions of the
arginine-rich DPR protein poly(GR), in which nucleolar
volume was almost double that of neurons without in-
clusions. This increased volume could be expected to in-
crease ribosomal biogenesis; however, initial studies in
vitro show reduced ribosomal RNA production when
the arginine-rich DPR proteins are overexpressed in cells
[13, 32]. These findings could suggest that the enlarged
nucleoli are dysfunctional rather than implying an
increased metabolism. Increases in nucleophosmin-
positive nucleolar size owing to the presence of poly(GR)
inclusions were replicated with another nucleolar
protein nucleolin, although no difference was detected
between control and C9FTLD cases. Both nucleophos-
min and nucleolin localise to the nucleolus, but
nucleophosmin is predominantly found in the granular
centre of nucleoli, and nucleolin in both the dense fibril-
lary centre and the granular centre of nucleoli. Volume
measurements for nucleolin were lower than those for
nucleophosmin, which might reflect differences in
detection sensitivity. Further work using super-resolution
microscopy would be required to investigate these sub-nu-
cleolar structures in more detail.
One discrepancy between cell models of C9FTLD/ALS
and patient tissue is the localisation of the poly(GR)
protein inclusions. In cells, short poly(GR) peptides
readily localise to the nucleolus where they exert the
aforementioned nucleolar enlargement and impaired
ribosome biogenesis [13]. By contrast, in patient brain,
poly(GR) protein is detected primarily in large cytoplas-
mic inclusions and occasionally in small dot-like perinu-
cleolar inclusions [1, 22]. Here, we have provided
evidence linking cytoplasmic poly(GR) inclusions in
patient tissue to changes in nucleolar volume, which has
previously only been detected in cell models. Although
Fig. 3 Expression of GR100, and to a lesser extent GA100, in Drosophila adult neurons is sufficient to increase nucleolar volume in inclusion-bearing
neurons. a Representative images of Drosophila brain expressing GR100 or GA100 in adult neurons using the elav-GeneSwitch (elavGS)
driver immunostained for the nucleolar protein fibrillarin (FIB, red), the dipeptide repeat (DPR) protein poly(GR) or poly(GA) (green), with DAPI nuclear stain
(blue); typical poly(GR) and poly(GA) inclusions are arrowed. Scale bar represents 2 μm. b, c Quantification of neuronal nucleolar volume determined by
fibrillarin immunoreactivity. Median nucleolar volume in Drosophila adult neurons expressing GR100 was significantly larger in neurons bearing poly(GR)
inclusions (GR+) than in neurons without inclusions (GR-) (b). Using the same scale as in b, the median nucleolar volume increase in Drosophila adult
neurons expressing GA100 is not apparent, highlighting the difference in magnitude of the changes; magnifying the scale (inset), reveals nucleolar volume
was significantly larger in neurons bearing poly(GA) inclusions (GA+) than in neurons without inclusions (GA-) (c). Controls in b and c are Drosophila
transgenic for DPR proteins that were not induced for gene expression. Each dot represents an individual fly, grey lines link medians from the same
individual fly in neurons with or without DPR protein inclusions, and average and SEM are shown as long and short horizontal bars, respectively. Significance
was determined by paired regression analysis: ***p < 0.001. Genotypes were: w; UAS-GR100/+; elavGS/+ (elavGS > GR100), w; UAS-GA100/+;
elavGS/+ (elavGS > GA100)
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poly(GR) protein is not detected in the nucleolus in
C9FTLD patient brain, cytoplasmic inclusions might be
present primarily in neurons that have a high poly(GR)
protein load, including soluble protein, undetectable by
the immunofluorescence methods used in this study.
It is likely that a proportion of the cytoplasmic
inclusions that are detected with poly(GR) immuno-
staining also contain some of the other dipeptide
repeat proteins, as the DPR proteins have previously
been shown to co-occur within individual inclusions
[21]. The most commonly occurring DPR protein
pathology is inclusions containing poly(GA) protein,
which also evoke neurotoxicity [18, 19, 35, 36]. How-
ever, we specifically investigated the effect of poly(GR)
and poly(GA) proteins on neuronal nucleoli in vivo,
and observed a much higher capability for poly(GR)
to evoke these changes than poly(GA) protein.
Poly(GR) protein is thus highly likely to be respon-
sible for the nucleolar enlargement associated with
the poly(GR) inclusion pathology that we have
detected in C9FTLD patient tissue.
As functional consequences of pathologies are difficult
to ascertain in post-mortem patient brain, whether
proteinaceous inclusions are toxic or whether they
represent a protective mechanism by sequestering more
toxic soluble protein species is often debated. Indeed, one
study found that although nucleolar size is decreased in
the brains of patients with Alzheimer’s disease compared
with controls, it is increased in patients with asymptom-
atic Alzheimer’s disease, who exhibit Aβ plaques and
neurofibrillary tangles but normal cognitive function [11],
suggesting that increased nucleolar volume could also
represent an early neuroprotective mechanism.
Surprisingly, we also uncovered a third association,
between C9orf72 repeat RNA pathology and nucleolar vol-
ume, albeit an association with a smaller effect size (1.2-fold
increase) than the change from the presence of poly(GR)
inclusions (1.8-fold increase). This nucleolar enlargement
was predominantly mediated by direct association of RNA
foci with the nucleolar structure, evidenced by a larger in-
crease in volume in nucleoli that colocalised with foci.
C9orf72 sense repeat RNA has previously been shown to be
Fig. 4 Nucleolar volume is increased in RNA foci-bearing neurons in C9FTLD patient brain. a Representative images of frontal cortex from a
heterozygous C9FTLD case immunostained for the nucleolar protein nucleophosmin (NPM, green), with RNA fluorescent in situ hybridisation for
sense RNA foci (red) and DAPI nuclear stain (blue); typical RNA foci-bearing (Foci+) and non foci-bearing (Foci-) neurons are highlighted with
dotted boxes. Scale bar represents 2 μm. b, c Quantification of neuronal nucleolar volume determined by nucleophosmin immunoreactivity.
Frequency distribution of pooled C9FTLD (heterozygous cases) nucleolar volumes show a slight shift to increased volumes in neurons bearing
RNA foci compared with neurons without foci (b). Median nucleolar volume in C9FTLD cases was significantly larger in neurons with RNA foci
compared with neurons without foci inclusions (c). Each dot represents an individual heterozygous C9FTLD case, grey lines link medians
from the same cases in neurons with or without RNA foci, and the average and SEM are shown as long and short horizontal bars,
respectively. Significance was determined by paired regression analysis: *p < 0.05
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able to interact with the nucleolar proteins in vitro [5, 10].
Depletion of RNA-binding proteins by RNA foci is
hypothesised to be a key pathomechanism in other non-
coding repeat expansion disorders, which are characterised
by certain RNA-binding proteins being found within RNA
foci. However, the localisation pattern of RNA foci and
nucleophosmin that we detected did not recapitulate these
findings, as RNA foci were generally detected on the edge
of nucleolar structures.
Rather than nucleolar enlargement representing an
increase in cell metabolism, it might infer a dispersal of the
normal physiological structure of the organelle. Membrane-
less structures such as nucleoli are dynamic and respond to
environmental conditions and cell stress, consequently
C9orf72 arginine-rich DPR proteins or repeat RNA could
either disrupt or prevent reformation of these structures.
Indeed, recent studies that examined the arginine-rich DPR
proteins interacting with LCD-containing proteins showed
perturbation of phase separation, a process thought to
recapitulate the formation of membraneless organelles
[14, 15]. In addition, the arginine-rich DPRs themlseves
can phase separate and alter the phase separation dynam-
ics of other proteins [3]. Alterations in membraneless
organelles other than the nucleolus have also been
observed in studies of C9FTD/ALS. Overexpression of
C9orf72 repeats in cells causes an increase in the percent-
age of cells containing stress granules [29]. In addition
overexpressed poly(GR) or poly(PR) in cells can local-
ise to [3, 35] and prevent the formation of stress granules
subjected to a stressor [32]. In C9FTD/ALS patient cells
repeat RNA is localised to FMRP-positive transport
granules [4], and both the number of stress granules [6]
and P bodies [10] are increased. In the case of repeat
RNA, nucleolar disruption might occur by sequestration
of nucleolar proteins by soluble RNA species which would
not be detected using the methodology in this study. The
presence of RNA foci could reflect cell nuclei in which the
concentration of retained repeat RNA is the highest, and
thus a nuclear environment in which this scenario is more
likely to occur.
In addition to effect size, the proportion of the C9FTLD
neuronal populations affected by the bidirectional nucle-
olar changes that we have observed are also important to
consider. Overall, in C9FTLD frontal cortical neurons a
25% reduction in nucleolar size exists compared with con-
trols. However, nucleolar size within these neurons is
clearly heterogeneous. The third of neurons that contain
RNA foci show a 1.2-fold nucleolar enlargement, and the
6% of neurons that contain poly(GR) inclusions show a
1.8-fold enlargement, compared with neurons without
these pathologies. While we can speculate on how this
change affects neuronal function within these subsets of
neurons, how functionality of the frontal cortex is affected
at a network level is unknown.
Conclusions
In conclusion, we have provided the first evidence for
nucleolar stress in C9FTLD patient brain, by using
three-dimensional volumetric imaging. Bidirectional
changes in nucleolar volume dependent on the presence
or absence of C9orf72 repeat RNA or protein patholo-
gies show the heterogeneity of pathomechanisms in
patient neurons, but support findings in current
experimental models and have important implications
for understanding the complex disease processes
involved in C9FTLD/ALS.
Additional file
Additional file 1: Table S1 and Figures S1-S7. Figure S1. No
difference in number of nucleophosmin-positive nucleoli or nuclear size
of neurons in C9FTLD patient brain compared with neurons from non-
neurodegenerative disease control brain. a Quantification of the number
of nucleophosmin (NPM)-positive nucleolar structures per neuron in
frontal cortex from C9FTLD patient brain (orange) and controls (blue).
Bars shown represent average and SEM of heterozygous cases. b Quanti-
fication of neuronal nuclear volume determined by DAPI staining (in
nucleophosmin-immunostained cases, Fig. 1). Median nuclear volume was no
different between neurons from C9FTLD cases and controls. Each dot rep-
resents an individual case with the homozygous C9FTLD case shown
in red and the average and SEM of heterozygous cases shown as long
and short horizontal bars, respectively. Significance was determined by
unpaired t test: ns = non-significant. c,d Correlation of nucleophosmin
and nuclear (DAPI) volumes per individual neuron in controls (c) and
C9FTLD patient brain (d). Nucleophosmin volume in controls and
C9FTLD cases was positively correlated with nuclear volume (p <
0.0001, both), but with a very low fit (R2 = 0.039 and 0.043 respect-
ively), therefore nucleolar volumes were not corrected for nuclear vol-
ume. Each dot represents values from an individual neuron, linear
regression in red. Figure S2. No difference in nucleolin volume be-
tween neurons from C9FTLD patient brain and neurologically-normal
controls. a Representative images of frontal cortex from
neurologically-normal controls and heterozygous (C9 Het) and homo-
zygous (C9 Hom) C9FTLD cases immunostained for the nucleolar pro-
tein nucleolin (NCL, green), the neuronal marker (NeuN, magenta)
with DAPI nuclear stain (blue). Scale bar represents 2 μm. b Quantifica-
tion of the number of nucleolin-positive nucleolar structures per neuron in
frontal cortex from C9FTLD patient brain (orange) and controls (blue). Bars
shown represent average and SEM of heterozygous cases. c,d Quantification of
neuronal nucleolar volume determined by nucleolin immunoreactivity. Fre-
quency distribution of pooled control and C9FTLD (heterozygous cases only)
nucleolin volumes were similar (c) and median nucleolin volume was no differ-
ent in neurons from C9FTLD cases and controls (d). e Quantification of neuronal
nuclear volume determined by DAPI staining. Median nuclear volume was no
different in neurons from C9FTLD cases and controls. In d and e, each dot repre-
sents an individual case with the homozygous C9FTLD case shown in red and
the average and SEM of heterozygous cases shown as long and short horizontal
bars, respectively. Significance was determined by unpaired t test: ns = non-signifi-
cant. f,g Correlation of nucleolin and nuclear (DAPI) volumes per individual neuron
in controls (f) and C9FTLD patient brain (g). Nucleolin volume in controls and
C9FTLD cases was positively correlated with nuclear volume (p<0.0001, both), but
with a very low fit (R2 = 0.038 and 0.091 respectively). Each dot represents
values from an individual neuron, linear regression in red. Figure S3. No dif-
ference in number of nucleophosmin-positive nucleoli or nuclear size of
neurons in poly(GR) inclusion-bearing neurons in C9FTLD patient brain than
in neurons without inclusions. a Quantification of the number of nucleo-
phosmin (NPM)-positive nucleolar structures per neuron in frontal cortex
from C9FTLD patient brain in neurons with (red, GR+) or without (orange,
GR-) poly(GR) inclusions. Bars shown represent average and SEM of hetero-
zygous cases. b Quantification of neuronal nuclear volume determined by
DAPI staining (in nucleophosmin-immunostained cases, Fig. 2). Median
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nuclear volume in C9FTLD cases was no different in neurons with poly(GR)
inclusions than in neurons without inclusions. Each dot represents an indi-
vidual case with the homozygous C9FTLD case shown in red, grey lines link
medians from the same cases in neurons with or without poly(GR) inclu-
sions, and the average and SEM of heterozygous cases are shown as long
and short horizontal bars, respectively. Significance was determined by
unpaired t test: ns = non-significant. Figure S4. Increased nucleolin
volume in poly(GR) inclusion-bearing neurons in C9FTLD patient brain. a
Representative images of frontal cortex from a heterozygous C9FTLD case
immunostained for the nucleolar protein nucleolin (NCL, green), poly(GR)
protein (red), the neuronal marker (NeuN, magenta) with DAPI nuclear stain
(blue); a typical poly(GR) inclusion is arrowed. Scale bar represents 2 μm. b
Quantification of the number of nucleolin-positive nucleolar structures per
neuron in frontal cortex from C9FTLD patient brain in neurons with (red, GR
+) or without (orange, GR-) poly(GR) inclusions. Bars shown represent aver-
age and SEM of heterozygous cases. c,d Quantification of neuronal nu-
cleolar volume determined by nucleolin immunoreactivity. Frequency
distribution analyses of pooled C9FTLD (heterozygous cases only) nucleolin
volumes show a shift to increased volume in neurons bearing poly(GR) inclusions
than in neurons without inclusions (c). Median nucleolin volume in C9FTLD cases
was significantly larger in neurons with poly(GR) inclusions than in neurons with-
out inclusions (d). e Quantification of neuronal nuclear volume determined
by DAPI staining (in nucleolin-immunostained cases). Median nuclear
volume in C9FTLD cases was no different in neurons with poly(GR) inclu-
sions than in neurons without inclusions. In d and e, each dot represents an
individual case with the homozygous C9FTLD case shown in red, grey lines
link medians from the same cases in neurons with or without poly(GR) in-
clusions, and the average and SEM of heterozygous cases shown as long
and short horizontal bars, respectively. Significance was determined by un-
paired t test: ***p < 0.001, ns = non-significant. Figure S5. Frequency of
poly(GR) and poly(GA) inclusions in Drosophila adult neurons. Quantification of
the percentage of neurons in Drosophila brain either induced or uninduced
with 200 μM RU486 for gene expression of GR(100) or GA(100) for 7 days
using the elav-GeneSwitch (elavGS) driver (pictures shown in Fig. 3). In both
GR(100) and GA(100) flies expression of the transgene led to approximately
7% of neurons bearing poly(GR) or poly(GA) inclusions, respectively, com-
pared to less than 1.5% in uninduced flies. The inclusions found in flies where
protein expression had not been induced are likely due to the known leaky
expression of the elav-GeneSwitch driver [1]. Bars represent the average and
SEM. Figure S6. Poly(GR) inclusion and RNA foci pathologies in C9FTLD pa-
tient brain are only occasionally found in the same neurons. a Representative
images of frontal cortex from heterozygous C9FTLD cases immunostained
for the nucleolar protein nucleophosmin (NPM, green), poly(GR) protein
(white) with RNA fluorescent in situ hybridisation for sense RNA foci (red)
and DAPI nuclear stain (blue); a neuron that contains an RNA focus but no
poly(GR) inclusion, and a rare neuron that contains both a poly(GR) inclusion and
an RNA focus (Foci +GR+) are highlighted with dotted boxes. Nucleophosmin
immunostaining was detected in poly(GR) inclusions (hollow arrow) due to
cross-reactivity of the secondary antibodies, and was excluded from ana-
lyses. Neurons with both pathologies were excluded from analysis in Fig. 3
in order to focus on the effects of RNA foci. Scale bar represents 2 μm. b,c
Quantification of the frequency of poly(GR) protein and RNA foci pathologies.
RNA foci are much more frequent than poly(GR) pathology overall (b) and in
all cases individually (c). The two pathologies do occasionally overlap, but no
more than would be expected by their relative frequencies. d Quantification
of the number of nucleophosmin-positive nucleolar structures per neuron in
frontal cortex from C9FTLD patient brain in neurons with (red, Foci+) or with-
out (orange, Foci-) RNA foci. Bars shown represent average and SEM of hetero-
zygous cases. e Quantification of neuronal nuclear volume determined by
DAPI staining from 4 out of 6 of the same cases (cases 9,12,14,18) using a pre-
viously published dataset [Mizielinska et al., 2013]. Median nuclear volume in
C9FTLD cases was no different in neurons with or without RNA foci. In b and e,
each dot represents an individual case, and the average and SEM of heterozy-
gous cases are shown as long and short horizontal bars, respectively. Significance
was determined by paired t test: ns = non-significant. Figure S7. Nucleolar vol-
ume in C9FTLD patient brain is increased to a greater extent in neurons bearing
RNA foci that are associated with the nucleolus than in neurons with foci in the
nucleoplasm. a Representative images of frontal cortex from a heterozygous
C9FTLD case immunostained for the nucleolar protein nucleophosmin (NPM,
green) with RNA fluorescent in situ hybridisation for sense RNA foci (red) and
DAPI nuclear stain (blue); panels show a neuron that contains an RNA focus asso-
ciated with a nucleophosmin-positive nucleoli (upper), and a neuron with a focus
in the nucleoplasm (lower). Scale bar represents 2 μm. b Quantification of the fre-
quency of RNA foci associated with nucleophosmin-positive nucleolar staining as
a percentage of total RNA foci. c Quantification of neuronal nucleolar volume de-
termined by nucleophosmin immunoreactivity. Median nucleolar volume in
C9FTLD cases was significantly larger in neurons with RNA foci associated with
nucleolar staining (nucleolar foci) than in neurons with foci in the nucleoplasm
(non-nucleolar foci). Individually 5 out of the 6 cases followed this trend. Each
dot represents an individual heterozygous C9FTLD case, grey lines link medians
from the same cases in neurons with RNA foci associated with either nucleolar
staining or the nucleoplasm, and the average and SEM are shown as long and
short horizontal bars, respectively. Significance was determined by paired regres-
sion analysis: **P < 0.01. (PDF 1494 kb)
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